Pharmaceutical

Flamingo gets grant from VLAIO to accelerate RNA-focuse...

The grant comes after Flamingo announced a deal in March 2023 to merge its opera...

Testosterone supplementation not linked to heart attack...

Testosterone supplementation in men with low levels of the hormone did not incre...

STAT+: Trade group scolds drugmaker for ‘unethical’ att...

A U.K. trade group has rebuked Leo Pharma over an incident in which a company ma...

STAT+: Pharmalittle: FDA cites another troubled plant a...

The FDA discovered another troubled plant run by Intas Pharmaceuticals, a generi...

Getting rid of bias in clinical calculators isn’t as si...

Getting rid of bias in clinical calculators isn't as simple as taking race out o...

Why it won’t be so easy for medicine to displace BMI

“I think the trend is moving away from BMI, but these entrenched issues don’t fa...

Opinion: The DNA from dog tumors may hold the secret to...

Genomic data from the tumors of more than 4,000 dogs is offering insights for tr...

Opinion: The FDA needs a risk evaluation and mitigation...

The problem with the new Alzheimer’s drugs isn’t the drugs.

FDA advisers endorse updating Covid vaccines to target ...

On Thursday, the FDA's scientific advisers said the next round of Covid vaccines...

A chatbot that’s cautious about GPT, AI pronouncements,...

In the latest edition of STAT's Health Tech newsletter: a chatbot that's cautiou...

Listen: Biogen’s messy board, Laronde’s data problem, &...

Can unicorns survive without data? Did biotech get over its skis? And what is go...

White House ‘naloxone summit’ omitting prominent advoca...

To combat the opioid crisis, the White House is convening naloxone makers, but l...

STAT+: USDA to push food producers to substantiate clai...

Claims that livestock are raised without antibiotics "must be backed by empirica...

Suicides and homicides among young Americans jumped ear...

In 2021, there were about 2,900 suicides in youths ages 10 to 19, and 4,200 in 2...

STAT+: Pharmalittle: PBMs are targeted in yet another c...

Expanded access to a new Alzheimer’s drug is unlikely to happen quickly even if ...

STAT+: Instead of credible data, PDS Biotech delivers ‘...

PDS Biotech's disclosures have been opaque and confusing — and maybe on purpose,...